High-risk sexual behaviors while on depot medroxyprogesterone acetate as compared to oral contraception

被引：2
|
作者：
Deborah Bartz
Rie Maurer
Jessica Kremen
Jennifer M. Fortin
Elizabeth Janiak
Alisa B. Goldberg
机构：
[1] Gynecology,The Department of Obstetrics
[2] and Reproductive Biology,Center for Clinical Investigation
[3] Brigham and Women’s Hospital,undefined
[4] Planned Parenthood League of Massachusetts,undefined
[5] Brigham and Women’s Hospital,undefined
来源：
Contraception and Reproductive Medicine | / 2卷 / 1期
关键词：
Sexual behavior; Depot medroxyprogesterone acetate; Oral contraceptive pills;
D O I：
10.1186/s40834-016-0035-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception
    Clark, MK
    Sowers, M
    Levy, BT
    Tenhundfeld, P
    FERTILITY AND STERILITY, 2001, 75 (05) : 871 - 877
  • [42] Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain
    Schlaff, WD
    Carson, SA
    Luciano, A
    Ross, D
    Bergqvist, A
    FERTILITY AND STERILITY, 2006, 85 (02) : 314 - 325
  • [43] DEPOT-MEDROXYPROGESTERONE ACETATE (DMPA) AND RISK OF LIVER-CANCER
    THOMAS, DB
    INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (02) : 182 - 185
  • [44] Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception
    Wanichsetakul, P
    Kamudhamas, A
    Watanaruangkovit, P
    Siripakarn, Y
    Visutakul, P
    CONTRACEPTION, 2002, 65 (06) : 407 - 410
  • [45] The effect of combined oral contraception and depot medroxyprogesterone acetate on brachial flow niediated dilatation and carotid arterial distensibility and stiffness index.
    Martins, W. P.
    Lizarelli, P. M.
    Vieira, C. S.
    Soares, G. M.
    Patta, M. C.
    Ferriani, R. A.
    FERTILITY AND STERILITY, 2007, 88 : S258 - S258
  • [46] RISK OF CERVICAL DYSPLASIA IN USERS OF ORAL-CONTRACEPTIVES, INTRAUTERINE-DEVICES OR DEPOT-MEDROXYPROGESTERONE ACETATE
    LIGGINS, G
    MACMAHON, B
    OLANOFF, LS
    REMINGTON, RD
    SEDDON, RJ
    SHEARMAN, RP
    WIED, GL
    TILLOTT, M
    FITZGERALD, N
    DRAKE, M
    YAMAUCHI, K
    HAWKINS, CM
    LEE, JG
    TONG, DM
    PENHALLEGON, RA
    TILLS, G
    AITKEN, L
    CAMERON, J
    GOOSTREY, SA
    BANDSTRA, B
    CONTRACEPTION, 1994, 50 (05) : 431 - 441
  • [47] EFFECT OF DURATION OF USE OF DEPOT MEDROXYPROGESTERONE ACETATE AND PSYCHOLOGICAL STRESS ON THE FEMALE SEXUAL FUNCTION
    Widjayanti, Yhenti
    Evi, Nurul
    Masfi, Achmad
    Rahmatika, Qory Tifani
    Sunaryo, Eri Yanuar Akhmad Budi
    Ramadhan, Muhammad Putra
    Aditya, Ronal Surya
    Mayvitana, Putu Dhea
    Putri, Berliana Devianti
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2023, 54 : 217 - 235
  • [48] Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir: Increased Tenofovir Diphosphate in Depot Medroxyprogesterone Acetate Users
    Thurman, Andrea
    Schwartz, Jill
    Brache, Vivian
    Chen, Beatrice
    Chandra, Neelima
    Kashuba, Angela
    Weiner, Debra
    Mauck, Christine
    Doncel, Gustavo F.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 342 - 342
  • [49] Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion
    Steinauer, Jody E.
    Upadhyay, Ushma D.
    Sokoloff, Abby
    Harper, Cynthia C.
    Diedrich, Justin T.
    Drey, Eleanor A.
    CONTRACEPTION, 2015, 92 (06) : 553 - 559
  • [50] Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception
    Renee Heffron
    Urvi M. Parikh
    Kerri J. Penrose
    Nelly Mugo
    Deborah Donnell
    Connie Celum
    John W. Mellors
    Jared M. Baeten
    AIDS and Behavior, 2017, 21 : 2173 - 2179
12345